Cannabidiol and Inflammation
Cannabidiol Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma
15/01/2019 by Vuolo et al., European Journal of Pharmacology
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
01/06/2018 by Petrosino et al., Journal of Pharmacology and Experimental Therapeutics
Cannabidiol (CBD) and its Analogs: A Review of Their Effects on Inflammation
04/01/2015 by Burstein Bioorganic & Medicinal Chemistry
Inflammation and Heart Failure
Innate immunity and the failing heart: the cytokine hypothesis revisited
27/03/2015 by Circulation Research
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
21/10/2014 by European Society of Cardiology
Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target
19/09/2014 by Heart Failure Reviews
The Global Health and Economic Burden of Hospitalizations for Heart Failure
01/04/2014 by Journal of the American College of Cardiology
Inflammation in Heart Failure with Preserved Ejection Fraction
01/04/2016 by Gomberg-Maitland et al., JACC: Heart Failure
Cannabidiol and Heart Failure
Cannabidiol Limits T Cell–Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
08/01/2016 by Molecular Medicine
Is the Cardiovascular system a Therapeutic target for Cannabidiol
02/02/2013 by British Journal of Clinical Pharmacology
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
14/12/2010 by Journal of the American College of Cardiology
